Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2017

Jul 11, 2017

29841_dirs_2017-07-11_94101972-e9c8-45cc-8009-e53363b96be2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-07-10

Reporting Person: Lenehan James T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-10 Ordinary Shares M 1010 $52.84 Acquired 46353 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-10 Stock Option (Right to Buy) $52.84 M 1010 Disposed 2017-09-01 Ordinary Shares (1010) Direct

Footnotes

F1: This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.